December 27, 2024

Richard Danforth
Chief Executive Officer
Genasys Inc.
16262 West Bernardo Drive
San Diego, CA 92127

       Re: Genasys Inc.
           Registration Statement on Form S-3
           Filed on December 20, 2024
           File No. 333-283977
Dear Richard Danforth:

       We have conducted a limited review of your registration statement and
have the
following comment.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments.

Form S-3 filed on December 20, 2024
General

1.     We note that your registration statement incorporates by reference your
Form 10-K
       for the fiscal year ended September 30, 2024, which in turn incorporates
by reference
       certain Part III information from a definitive proxy statement that you
have not yet
       filed. Please be advised that we cannot accelerate the effective date of
your
       registration statement until you have amended your Form 10-K to include
the Part
       III information or have filed a proxy statement which includes such
information. For
       guidance, please refer to Question 123.01 of the Securities Act Forms
Compliance and
       Disclosure Interpretations.
       We remind you that the company and its management are responsible for
the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action
or absence
 December 27, 2024
Page 2

of action by the staff.

       Refer to Rules 460 and 461 regarding requests for acceleration. Please
allow adequate
time for us to review any amendment prior to the requested effective date of
the registration
statement.

       Please contact Sarah Sidwell at 202-551-4733 or Jennifer Angelini at
202-551-3047
with any other questions.



                                                           Sincerely,

                                                           Division of
Corporation Finance
                                                           Office of
Manufacturing
cc:    Joshua Little